Goldman Sachs downgraded Cardinal Health (NYSE:CAH) from Buy to Neutral in a report released today.
- Updated: September 16, 2016
Only yesterday Cardinal Health (NYSE:CAH) traded 0.91% lower at $76.60. CAH’s 50-day moving average is $81.46 and its 200-day moving average is $80.81. The last close is down 6.07% from the 200-day average, compared to the S&P 500 Index which has decreased -0.01% over the date range. 716,266 shares of Cardinal Health were exchanged, down from ann average trading volume of 2,134,280.
Goldman Sachs has downgraded Cardinal Health(NYSE:CAH) from Buy to Neutral in a statement released 9/16/2016.
Previously on 8/04/2016, Deutsche Bank reported on Cardinal Health(NYSE:CAH) upped the target price from $83.00 to $89.00 that indicated a possible upside of 0.06%.
See Chart Below:
In addition to Goldman Sachs reporting it’s stock price target, a total of 15 firms have reported on the company. The one year target is $91.93 with seven analysts rating the stock a strong buy, five firms rating the stock a buy, seven analysts rating the stock a hold, 0 rating the company to underperform, and lastly 0 firms rating the company as sell.
Cardinal Health has a P/E of 18 with a 52 week low of $73.25 and a 52 week high of $91.23 and has a total market value of $0.0.
General Company Details For Cardinal Health (NYSE:CAH)
Cardinal Health, Inc. is a healthcare services and products company. The Company operates through two segments: Pharmaceutical and Medical. The Pharmaceutical segment distributes branded and generic pharmaceutical, specialty pharmaceutical, over-the-counter healthcare and consumer products. This segment also operates nuclear pharmacies and cyclotron facilities; provides pharmacy management services to hospitals, as well as medication therapy management and patient outcomes services to hospitals, other healthcare providers and payers, and provides services to healthcare companies. The Medical segment distributes a range of medical, surgical and laboratory products, and provides services to hospitals, ambulatory surgery centers, clinical laboratories and other healthcare providers. This segment also manufactures, sources and develops its own Cardinal Health brand medical and surgical products. It provides post-acute care management and transition services, and and software to hospitals.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with MarketBeat.com's FREE daily email newsletter.